HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens (357 views visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2012 Sep 17; 7(8): N/D-N/D.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Abstract, Conference,
Impact factor: 3.73, 5-year impact factor Impact factor a 5 anni: 4.244
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84865094442&partnerID=40&md5=da2968418492c10caff0bafe91f2d318
Keywords Parole chiave: Env Antigen, Epitope, Gag Protein, Human Immunodeficiency Virus Antigen, Human Immunodeficiency Virus Protein, Monoclonal Antibody, Scaffold Protein, Unclassified Drug, Article, Enzyme Activity, Nonhuman, Protein Analysis, Protein Binding, Protein Conformation, Protein Expression, Protein Function, Protein Structure, Structure Analysis, Antibodies, Neutralizing, Enzyme-Linked Immunosorbent Assay, Hiv Core Protein P24, Hiv Envelope Protein Gp120, Microscopy, Electron, Peptide Fragments,
Affiliations Affiliazioni:
*** IBB - CNR ***
Laboratory of Molecular Biology and Viral Oncogenesis, AIDS Reference Center, Istituto Nazionale Tumori Fond. G. Pascale, Naples, Italy
Department of Biological Science-School of Biotechnological Sciences, University of Naples Federico II, Naples, Italy
National Resource Council, Institute of Biostructure and Bioimaging, Naples, Italy
Molsoft LLC, La Jolla, CA, United States
References Riferimenti:
Ross, A.L., Brave, A., Scarlatti, G., Manrique, A., Buonaguro, L., Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference (2010) Lancet Infect.Dis, 10, pp. 305-31
Boutwell, C.L., Rolland, M.M., Herbeck, J.T., Mullins, J.I., Allen, T.M., Viral evolution and escape during acute HIV-1 infection (2010) J.Infect.Dis, 202, pp. S309-S314
Doria-Rose, N.A., Klein, R.M., Daniels, M.G., O'Dell, S., Nason, M., Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables (2010) Journal of Virology, 84, pp. 1631-1636
Walker, L.M., Simek, M.D., Priddy, F., Gach, J.S., Wagner, D., A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals (2010) PLoS.Pathog, 6
Cheng-Mayer, C., Homsy, J., Evans, L.A., Levy, J.A., Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization (1988) Proceedings of National Academy of Science USA, 85, pp. 2815-2819
Dhillon, A.K., Donners, H., Pantophlet, R., Johnson, W.E., Decker, J.M., Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors (2007) Journal of Virology, 81, pp. 6548-6562
Sather, D.N., Stamatatos, L., Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects (2010) Vaccine, 28, pp. B8-12
Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody (1994) Science, 266, pp. 1024-1027
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of Human Immunodeficiency Virus type 1 (1996) Journal of Virology, 70, pp. 1100-1108
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 (1993) Journal of Virology, 67, pp. 6642-6647
Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1 (2001) AIDS Research and Human Retroviruses, 17, pp. 1757-1765
Walker, L.M., Phogat, S.K., Chan-Hui, P.Y., Wagner, D., Phung, P., Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target (2009) Science, 326, pp. 285-289
Wu, X., Yang, Z.Y., Li, Y., Hogerkorp, C.M., Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 (2010) Science, 329, pp. 856-861. , Schief WR, et al
Corti, D., Langedijk, J.P., Hinz, A., Seaman, M.S., Vanzetta, F., Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals (2010) PLoS.One, 5, pp. e8805-
Gorny, M.K., Williams, C., Volsky, B., Revesz, K., Wang, X.H., Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1 (2006) Journal of Virology, 80, pp. 6865-6872
Bell, C.H., Pantophlet, R., Schiefner, A., Cavacini, L.A., Stanfield, R.L., Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization (2008) J.Mol.Biol, 375, pp. 969-978
Pantophlet, R., Wrin, T., Cavacini, L.A., Robinson, J.E., Burton, D.R., Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity (2008) Virology, 381, pp. 251-260
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J.R., Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope (2004) Journal of Virology, 78, pp. 10724-10737
Brunel, F.M., Zwick, M.B., Cardoso, R.M., Nelson, J.D., Wilson, I.A., Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody (2006) Journal of Virology, 80, pp. 1680-1687
Zhou, T., Xu, L., Dey, B., Hessell, A.J., van, R.D., Structural definition of a conserved neutralization epitope on HIV-1 gp120 (2007) Nature, 445, pp. 732-737
Stanfield, R.L., Gorny, M.K., Williams, C., Zolla-Pazner, S., Wilson, I.A., Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D (2004) Structure, 12, pp. 193-204
Ofek, G., Guenaga, F.J., Schief, W.R., Skinner, J., Baker, D., Elicitation of structure-specific antibodies by epitope scaffolds (2010) Proc.Natl.Acad.Sci.U.S.A, 107, pp. 17880-17887
Guenaga, J., Dosenovic, P., Ofek, G., Baker, D., Schief, W.R., Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant (2011) PLoS.One, 6, pp. e16074-
Chakraborty, K., Durani, V., Miranda, E.R., Citron, M., Liang, X., Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies (2006) Biochem.J, 399, pp. 483-491
Totrov, M., Jiang, X., Kong, X.P., Cohen, S., Krachmarov, C., Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold (2010) Virology, 405, pp. 513-523
Zinkernagel, R.M., LaMarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A.F., Neutralizing antiviral antibody responses (2001) Adv.Immunol, 79, pp. 1-53
Bachmann, M.F., Hengartner, H., Zinkernagel, R.M., T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction (1995) European Joutnal of Immunology, 25, pp. 3445-3451
Netter, H.J., Macnaughton, T.B., Woo, W.P., Tindle, R., Gowans, E.J., Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes (2001) Journal of Virology, 75, pp. 2130-2141
Nardin, E.H., Oliveira, G.A., Calvo-Calle, J.M., Wetzel, K., Maier, C., Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes (2004) Infection and Immunity, 72, pp. 6519-6527
Schellenbacher, C., Roden, R., Kirnbauer, R., Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines (2009) Journal of Virology, 83, pp. 10085-10095
Buonaguro, L., Tornesello, M.L., Buonaguro, F.M., Virus-Like Particles as Particulate Vaccines (2010) Curr.HIV Res, 8, pp. 299-399
Vietheer, P.T., Boo, I., Drummer, H.E., Netter, H.J., Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies (2007) Antivir.Ther, 12, pp. 477-487
Buonaguro, L., Buonaguro, F.M., Tornesello, M.L., Mantas, D., Beth-Giraldo, E., High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A (2001) Antiviral Research, 49, pp. 35-47
Crooks, E.T., Moore, P.L., Franti, M., Cayanan, C.S., Zhu, P., A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120 (2007) Virology, 366, pp. 245-262
Wang, B.Z., Liu, W., Kang, S.M., Alam, M., Huang, C., Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles (2007) Journal of Virology, 81, pp. 10869-10878
Pornillos, O., Ganser-Pornillos, B.K., Kelly, B.N., Hua, Y., Whitby, F.G., X-ray structures of the hexameric building block of the HIV capsid (2009) Cell, 137, pp. 1282-1292
Buonaguro, L., Tagliamonte, M., Tornesello, M.L., Buonaguro, F.M., Can HIV p24 Be a Suitable Scaffold for Presenting Env Antigens? (2011) Clin.Vaccine Immunol, 18, pp. 2003-2004
Huang, C.C., Tang, M., Zhang, M.Y., Majeed, S., Montabana, E., Structure of a V3-containing HIV-1 gp120 core (2005) Science, 310, pp. 1025-1028
Abagyan, R., Totrov, M., Kuznetsov, D., ICM-A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation (1994) J.Comp.Chem, 15, pp. 488-506
von Schwedler, U.K., Stemmler, T.L., Klishko, V.Y., Li, S., Albertine, K.H., Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly (1998) EMBO J, 17, pp. 1555-1568
Gross, I., Hohenberg, H., Krausslich, H.G., In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus (1997) Eur.J.Biochem, 249, pp. 592-600
Martelli, G.P., Russo, M., Use of thin sectioning for the visualization and identification of plant virus (1984) Methods in Virology, 8, pp. 143-224
Johnsson, B., Lofas, S., Lindquist, G., Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors (1991) Anal.Biochem, 198, pp. 268-277
Gorny, M.K., Conley, A.J., Karwowska, S., Buchbinder, A., Xu, J.Y., Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody (1992) Journal of Virology, 66, pp. 7538-7542
Ehrlich, L.S., Agresta, B.E., Carter, C.A., Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro (1992) Journal of Virology, 66, pp. 4874-4883
Cardoso, R.M., Zwick, M.B., Stanfield, R.L., Kunert, R., Binley, J.M., Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41 (2005) Immunity, 22, pp. 163-173
Hinton, H.J., Jegerlehner, A., Bachmann, M.F., Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors (2008) Curr Top Microbiol Immunol, 319, pp. 1-15
Vos, Q., Lees, A., Wu, Z.Q., Snapper, C.M., Mond, J.J., B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms (2000) Immunol.Rev, 176, pp. 154-170
Ruedl, C., Storni, T., Lechner, F., Bachi, T., Bachmann, M.F., Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP (2002) European Joutnal of Immunology, 32, pp. 818-825
Bachmann, M.F., Lutz, M.B., Layton, G.T., Harris, S.J., Fehr, T., Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes (1996) European Joutnal of Immunology, 26, pp. 2595-2600
Ross, A. L., Brave, A., Scarlatti, G., Manrique, A., Buonaguro, L., Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference (2010) Lancet Infect. Dis, 10, pp. 305-31
Boutwell, C. L., Rolland, M. M., Herbeck, J. T., Mullins, J. I., Allen, T. M., Viral evolution and escape during acute HIV-1 infection (2010) J. Infect. Dis, 202, pp. S309-S314
Doria-Rose, N. A., Klein, R. M., Daniels, M. G., O'Dell, S., Nason, M., Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables (2010) Journal of Virology, 84, pp. 1631-1636
Walker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals (2010) PLoS. Pathog, 6
Dhillon, A. K., Donners, H., Pantophlet, R., Johnson, W. E., Decker, J. M., Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors (2007) Journal of Virology, 81, pp. 6548-6562
Sather, D. N., Stamatatos, L., Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects (2010) Vaccine, 28, pp. B8-12
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody (1994) Science, 266, pp. 1024-1027
Walker, L. M., Phogat, S. K., Chan-Hui, P. Y., Wagner, D., Phung, P., Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target (2009) Science, 326, pp. 285-289
Wu, X., Yang, Z. Y., Li, Y., Hogerkorp, C. M., Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 (2010) Science, 329, pp. 856-861. , Schief WR, et al
Gorny, M. K., Williams, C., Volsky, B., Revesz, K., Wang, X. H., Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1 (2006) Journal of Virology, 80, pp. 6865-6872
Bell, C. H., Pantophlet, R., Schiefner, A., Cavacini, L. A., Stanfield, R. L., Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization (2008) J. Mol. Biol, 375, pp. 969-978
Brunel, F. M., Zwick, M. B., Cardoso, R. M., Nelson, J. D., Wilson, I. A., Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody (2006) Journal of Virology, 80, pp. 1680-1687
Stanfield, R. L., Gorny, M. K., Williams, C., Zolla-Pazner, S., Wilson, I. A., Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D (2004) Structure, 12, pp. 193-204
Zinkernagel, R. M., LaMarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A. F., Neutralizing antiviral antibody responses (2001) Adv. Immunol, 79, pp. 1-53
Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction (1995) European Joutnal of Immunology, 25, pp. 3445-3451
Netter, H. J., Macnaughton, T. B., Woo, W. P., Tindle, R., Gowans, E. J., Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes (2001) Journal of Virology, 75, pp. 2130-2141
Nardin, E. H., Oliveira, G. A., Calvo-Calle, J. M., Wetzel, K., Maier, C., Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes (2004) Infection and Immunity, 72, pp. 6519-6527
Vietheer, P. T., Boo, I., Drummer, H. E., Netter, H. J., Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies (2007) Antivir. Ther, 12, pp. 477-487
Crooks, E. T., Moore, P. L., Franti, M., Cayanan, C. S., Zhu, P., A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120 (2007) Virology, 366, pp. 245-262
Wang, B. Z., Liu, W., Kang, S. M., Alam, M., Huang, C., Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles (2007) Journal of Virology, 81, pp. 10869-10878
Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Structure of a V3-containing HIV-1 gp120 core (2005) Science, 310, pp. 1025-1028
von Schwedler, U. K., Stemmler, T. L., Klishko, V. Y., Li, S., Albertine, K. H., Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly (1998) EMBO J, 17, pp. 1555-1568
Martelli, G. P., Russo, M., Use of thin sectioning for the visualization and identification of plant virus (1984) Methods in Virology, 8, pp. 143-224
Gorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody (1992) Journal of Virology, 66, pp. 7538-7542
Ehrlich, L. S., Agresta, B. E., Carter, C. A., Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro (1992) Journal of Virology, 66, pp. 4874-4883
Cardoso, R. M., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41 (2005) Immunity, 22, pp. 163-173
Hinton, H. J., Jegerlehner, A., Bachmann, M. F., Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors (2008) Curr Top Microbiol Immunol, 319, pp. 1-15
Bachmann, M. F., Lutz, M. B., Layton, G. T., Harris, S. J., Fehr, T., Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes (1996) European Joutnal of Immunology, 26, pp. 2595-2600
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2012 Sep 17; 7(8): N/D-N/D.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Abstract, Conference,
Impact factor: 3.73, 5-year impact factor Impact factor a 5 anni: 4.244
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84865094442&partnerID=40&md5=da2968418492c10caff0bafe91f2d318
Keywords Parole chiave: Env Antigen, Epitope, Gag Protein, Human Immunodeficiency Virus Antigen, Human Immunodeficiency Virus Protein, Monoclonal Antibody, Scaffold Protein, Unclassified Drug, Article, Enzyme Activity, Nonhuman, Protein Analysis, Protein Binding, Protein Conformation, Protein Expression, Protein Function, Protein Structure, Structure Analysis, Antibodies, Neutralizing, Enzyme-Linked Immunosorbent Assay, Hiv Core Protein P24, Hiv Envelope Protein Gp120, Microscopy, Electron, Peptide Fragments,
Affiliations Affiliazioni:
*** IBB - CNR ***
Laboratory of Molecular Biology and Viral Oncogenesis, AIDS Reference Center, Istituto Nazionale Tumori Fond. G. Pascale, Naples, Italy
Department of Biological Science-School of Biotechnological Sciences, University of Naples Federico II, Naples, Italy
National Resource Council, Institute of Biostructure and Bioimaging, Naples, Italy
Molsoft LLC, La Jolla, CA, United States
References Riferimenti:
Ross, A.L., Brave, A., Scarlatti, G., Manrique, A., Buonaguro, L., Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference (2010) Lancet Infect.Dis, 10, pp. 305-31
Boutwell, C.L., Rolland, M.M., Herbeck, J.T., Mullins, J.I., Allen, T.M., Viral evolution and escape during acute HIV-1 infection (2010) J.Infect.Dis, 202, pp. S309-S314
Doria-Rose, N.A., Klein, R.M., Daniels, M.G., O'Dell, S., Nason, M., Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables (2010) Journal of Virology, 84, pp. 1631-1636
Walker, L.M., Simek, M.D., Priddy, F., Gach, J.S., Wagner, D., A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals (2010) PLoS.Pathog, 6
Cheng-Mayer, C., Homsy, J., Evans, L.A., Levy, J.A., Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization (1988) Proceedings of National Academy of Science USA, 85, pp. 2815-2819
Dhillon, A.K., Donners, H., Pantophlet, R., Johnson, W.E., Decker, J.M., Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors (2007) Journal of Virology, 81, pp. 6548-6562
Sather, D.N., Stamatatos, L., Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects (2010) Vaccine, 28, pp. B8-12
Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody (1994) Science, 266, pp. 1024-1027
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of Human Immunodeficiency Virus type 1 (1996) Journal of Virology, 70, pp. 1100-1108
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 (1993) Journal of Virology, 67, pp. 6642-6647
Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1 (2001) AIDS Research and Human Retroviruses, 17, pp. 1757-1765
Walker, L.M., Phogat, S.K., Chan-Hui, P.Y., Wagner, D., Phung, P., Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target (2009) Science, 326, pp. 285-289
Wu, X., Yang, Z.Y., Li, Y., Hogerkorp, C.M., Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 (2010) Science, 329, pp. 856-861. , Schief WR, et al
Corti, D., Langedijk, J.P., Hinz, A., Seaman, M.S., Vanzetta, F., Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals (2010) PLoS.One, 5, pp. e8805-
Gorny, M.K., Williams, C., Volsky, B., Revesz, K., Wang, X.H., Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1 (2006) Journal of Virology, 80, pp. 6865-6872
Bell, C.H., Pantophlet, R., Schiefner, A., Cavacini, L.A., Stanfield, R.L., Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization (2008) J.Mol.Biol, 375, pp. 969-978
Pantophlet, R., Wrin, T., Cavacini, L.A., Robinson, J.E., Burton, D.R., Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity (2008) Virology, 381, pp. 251-260
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J.R., Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope (2004) Journal of Virology, 78, pp. 10724-10737
Brunel, F.M., Zwick, M.B., Cardoso, R.M., Nelson, J.D., Wilson, I.A., Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody (2006) Journal of Virology, 80, pp. 1680-1687
Zhou, T., Xu, L., Dey, B., Hessell, A.J., van, R.D., Structural definition of a conserved neutralization epitope on HIV-1 gp120 (2007) Nature, 445, pp. 732-737
Stanfield, R.L., Gorny, M.K., Williams, C., Zolla-Pazner, S., Wilson, I.A., Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D (2004) Structure, 12, pp. 193-204
Ofek, G., Guenaga, F.J., Schief, W.R., Skinner, J., Baker, D., Elicitation of structure-specific antibodies by epitope scaffolds (2010) Proc.Natl.Acad.Sci.U.S.A, 107, pp. 17880-17887
Guenaga, J., Dosenovic, P., Ofek, G., Baker, D., Schief, W.R., Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant (2011) PLoS.One, 6, pp. e16074-
Chakraborty, K., Durani, V., Miranda, E.R., Citron, M., Liang, X., Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies (2006) Biochem.J, 399, pp. 483-491
Totrov, M., Jiang, X., Kong, X.P., Cohen, S., Krachmarov, C., Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold (2010) Virology, 405, pp. 513-523
Zinkernagel, R.M., LaMarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A.F., Neutralizing antiviral antibody responses (2001) Adv.Immunol, 79, pp. 1-53
Bachmann, M.F., Hengartner, H., Zinkernagel, R.M., T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction (1995) European Joutnal of Immunology, 25, pp. 3445-3451
Netter, H.J., Macnaughton, T.B., Woo, W.P., Tindle, R., Gowans, E.J., Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes (2001) Journal of Virology, 75, pp. 2130-2141
Nardin, E.H., Oliveira, G.A., Calvo-Calle, J.M., Wetzel, K., Maier, C., Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes (2004) Infection and Immunity, 72, pp. 6519-6527
Schellenbacher, C., Roden, R., Kirnbauer, R., Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines (2009) Journal of Virology, 83, pp. 10085-10095
Buonaguro, L., Tornesello, M.L., Buonaguro, F.M., Virus-Like Particles as Particulate Vaccines (2010) Curr.HIV Res, 8, pp. 299-399
Vietheer, P.T., Boo, I., Drummer, H.E., Netter, H.J., Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies (2007) Antivir.Ther, 12, pp. 477-487
Buonaguro, L., Buonaguro, F.M., Tornesello, M.L., Mantas, D., Beth-Giraldo, E., High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A (2001) Antiviral Research, 49, pp. 35-47
Crooks, E.T., Moore, P.L., Franti, M., Cayanan, C.S., Zhu, P., A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120 (2007) Virology, 366, pp. 245-262
Wang, B.Z., Liu, W., Kang, S.M., Alam, M., Huang, C., Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles (2007) Journal of Virology, 81, pp. 10869-10878
Pornillos, O., Ganser-Pornillos, B.K., Kelly, B.N., Hua, Y., Whitby, F.G., X-ray structures of the hexameric building block of the HIV capsid (2009) Cell, 137, pp. 1282-1292
Buonaguro, L., Tagliamonte, M., Tornesello, M.L., Buonaguro, F.M., Can HIV p24 Be a Suitable Scaffold for Presenting Env Antigens? (2011) Clin.Vaccine Immunol, 18, pp. 2003-2004
Huang, C.C., Tang, M., Zhang, M.Y., Majeed, S., Montabana, E., Structure of a V3-containing HIV-1 gp120 core (2005) Science, 310, pp. 1025-1028
Abagyan, R., Totrov, M., Kuznetsov, D., ICM-A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation (1994) J.Comp.Chem, 15, pp. 488-506
von Schwedler, U.K., Stemmler, T.L., Klishko, V.Y., Li, S., Albertine, K.H., Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly (1998) EMBO J, 17, pp. 1555-1568
Gross, I., Hohenberg, H., Krausslich, H.G., In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus (1997) Eur.J.Biochem, 249, pp. 592-600
Martelli, G.P., Russo, M., Use of thin sectioning for the visualization and identification of plant virus (1984) Methods in Virology, 8, pp. 143-224
Johnsson, B., Lofas, S., Lindquist, G., Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors (1991) Anal.Biochem, 198, pp. 268-277
Gorny, M.K., Conley, A.J., Karwowska, S., Buchbinder, A., Xu, J.Y., Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody (1992) Journal of Virology, 66, pp. 7538-7542
Ehrlich, L.S., Agresta, B.E., Carter, C.A., Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro (1992) Journal of Virology, 66, pp. 4874-4883
Cardoso, R.M., Zwick, M.B., Stanfield, R.L., Kunert, R., Binley, J.M., Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41 (2005) Immunity, 22, pp. 163-173
Hinton, H.J., Jegerlehner, A., Bachmann, M.F., Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors (2008) Curr Top Microbiol Immunol, 319, pp. 1-15
Vos, Q., Lees, A., Wu, Z.Q., Snapper, C.M., Mond, J.J., B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms (2000) Immunol.Rev, 176, pp. 154-170
Ruedl, C., Storni, T., Lechner, F., Bachi, T., Bachmann, M.F., Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP (2002) European Joutnal of Immunology, 32, pp. 818-825
Bachmann, M.F., Lutz, M.B., Layton, G.T., Harris, S.J., Fehr, T., Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes (1996) European Joutnal of Immunology, 26, pp. 2595-2600
Ross, A. L., Brave, A., Scarlatti, G., Manrique, A., Buonaguro, L., Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference (2010) Lancet Infect. Dis, 10, pp. 305-31
Boutwell, C. L., Rolland, M. M., Herbeck, J. T., Mullins, J. I., Allen, T. M., Viral evolution and escape during acute HIV-1 infection (2010) J. Infect. Dis, 202, pp. S309-S314
Doria-Rose, N. A., Klein, R. M., Daniels, M. G., O'Dell, S., Nason, M., Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables (2010) Journal of Virology, 84, pp. 1631-1636
Walker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals (2010) PLoS. Pathog, 6
Dhillon, A. K., Donners, H., Pantophlet, R., Johnson, W. E., Decker, J. M., Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors (2007) Journal of Virology, 81, pp. 6548-6562
Sather, D. N., Stamatatos, L., Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects (2010) Vaccine, 28, pp. B8-12
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody (1994) Science, 266, pp. 1024-1027
Walker, L. M., Phogat, S. K., Chan-Hui, P. Y., Wagner, D., Phung, P., Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target (2009) Science, 326, pp. 285-289
Wu, X., Yang, Z. Y., Li, Y., Hogerkorp, C. M., Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 (2010) Science, 329, pp. 856-861. , Schief WR, et al
Gorny, M. K., Williams, C., Volsky, B., Revesz, K., Wang, X. H., Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1 (2006) Journal of Virology, 80, pp. 6865-6872
Bell, C. H., Pantophlet, R., Schiefner, A., Cavacini, L. A., Stanfield, R. L., Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization (2008) J. Mol. Biol, 375, pp. 969-978
Brunel, F. M., Zwick, M. B., Cardoso, R. M., Nelson, J. D., Wilson, I. A., Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody (2006) Journal of Virology, 80, pp. 1680-1687
Stanfield, R. L., Gorny, M. K., Williams, C., Zolla-Pazner, S., Wilson, I. A., Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D (2004) Structure, 12, pp. 193-204
Zinkernagel, R. M., LaMarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A. F., Neutralizing antiviral antibody responses (2001) Adv. Immunol, 79, pp. 1-53
Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction (1995) European Joutnal of Immunology, 25, pp. 3445-3451
Netter, H. J., Macnaughton, T. B., Woo, W. P., Tindle, R., Gowans, E. J., Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes (2001) Journal of Virology, 75, pp. 2130-2141
Nardin, E. H., Oliveira, G. A., Calvo-Calle, J. M., Wetzel, K., Maier, C., Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes (2004) Infection and Immunity, 72, pp. 6519-6527
Vietheer, P. T., Boo, I., Drummer, H. E., Netter, H. J., Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies (2007) Antivir. Ther, 12, pp. 477-487
Crooks, E. T., Moore, P. L., Franti, M., Cayanan, C. S., Zhu, P., A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120 (2007) Virology, 366, pp. 245-262
Wang, B. Z., Liu, W., Kang, S. M., Alam, M., Huang, C., Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles (2007) Journal of Virology, 81, pp. 10869-10878
Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Structure of a V3-containing HIV-1 gp120 core (2005) Science, 310, pp. 1025-1028
von Schwedler, U. K., Stemmler, T. L., Klishko, V. Y., Li, S., Albertine, K. H., Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly (1998) EMBO J, 17, pp. 1555-1568
Martelli, G. P., Russo, M., Use of thin sectioning for the visualization and identification of plant virus (1984) Methods in Virology, 8, pp. 143-224
Gorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody (1992) Journal of Virology, 66, pp. 7538-7542
Ehrlich, L. S., Agresta, B. E., Carter, C. A., Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro (1992) Journal of Virology, 66, pp. 4874-4883
Cardoso, R. M., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41 (2005) Immunity, 22, pp. 163-173
Hinton, H. J., Jegerlehner, A., Bachmann, M. F., Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors (2008) Curr Top Microbiol Immunol, 319, pp. 1-15
Bachmann, M. F., Lutz, M. B., Layton, G. T., Harris, S. J., Fehr, T., Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes (1996) European Joutnal of Immunology, 26, pp. 2595-2600
HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
Heterologous protein scaffolds engrafted with structurally defined HIV Env epitopes recognized by broadly neutralizing monoclonal antibodies (MAbs) represent a promising strategy to elicit broad neutralizing antibodies. In such regards, a protein scaffold based on the HIV p24 CA protein is a highly attractive approach, providing also Gag epitopes for eliciting HIV non-neutralizing protective antibodies and specific CD4+ and CD8+ T cell responses. In the present study, computational techniques were employed to verify the presence of acceptor sites for conformational HIV Env epitopes and, as proof of concept, the analysis of HIV p24 CA-based scaffolds using a complete V3 loop in a MAb-bound conformation is presented. The V3-p24 epitope-scaffold proteins show the formation of capsomers made of hexamers similarly to the p24 wild type protein. Moreover, the conformational V3 loop presented on p24 scaffold is recognized by a panel of anti-V3 MAbs. The results suggest that HIV p24 CA protein has suitable acceptor sites for engrafting foreign epitopes, without disrupting the formation of capsomer hexamer structures, and that the V3 epitope does retain its antibody-bound conformation. This strongly support the feasibility of developing a scaffolding strategy based on p24 CA proteins displaying conformational minimal structural, antigenic HIV Env epitopes. © 2012 Tagliamonte et al.
Heterologous protein scaffolds engrafted with structurally defined HIV Env epitopes recognized by broadly neutralizing monoclonal antibodies (MAbs) represent a promising strategy to elicit broad neutralizing antibodies. In such regards, a protein scaffold based on the HIV p24 CA protein is a highly attractive approach, providing also Gag epitopes for eliciting HIV non-neutralizing protective antibodies and specific CD4+ and CD8+ T cell responses. In the present study, computational techniques were employed to verify the presence of acceptor sites for conformational HIV Env epitopes and, as proof of concept, the analysis of HIV p24 CA-based scaffolds using a complete V3 loop in a MAb-bound conformation is presented. The V3-p24 epitope-scaffold proteins show the formation of capsomers made of hexamers similarly to the p24 wild type protein. Moreover, the conformational V3 loop presented on p24 scaffold is recognized by a panel of anti-V3 MAbs. The results suggest that HIV p24 CA protein has suitable acceptor sites for engrafting foreign epitopes, without disrupting the formation of capsomer hexamer structures, and that the V3 epitope does retain its antibody-bound conformation. This strongly support the feasibility of developing a scaffolding strategy based on p24 CA proteins displaying conformational minimal structural, antigenic HIV Env epitopes. © 2012 Tagliamonte et al.
HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
Sivaccumar JP, Leonardi A, Iaccarino E, Corvino G, Sanguigno L, Chambery A, Russo R, Valletta M, Latino D, Capasso D, Doti N, Ruvo M, Sandomenico A
* Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry (3 visite)
Int J Mol Sci (ISSN: 1422-0067linking), 2021 Mar 20; 22(6): N/D-N/D.
Impact Factor: 4.556
Dettagli Esporta in BibTeX Esporta in EndNote
Camorani S, Passariello M, Agnello L, Esposito S, Collina F, Cantile M, Di Bonito M, Ulasov IV, Fedele M, Zannetti A, De Lorenzo C, Cerchia L
* Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer (78 visite) (PDF 41 visite)
J Exp Clin Cancer Res (ISSN: 0392-9078linking), 2020 Sep 7; 39(1): 180-180.
Impact Factor: 7.068
Dettagli Esporta in BibTeX Esporta in EndNote
Sivaccumar J, Sandomenico A, Vitagliano L, Ruvo M
* Monoclonal antibodies: A prospective and retrospective view (47 visite)
Curr Med Chem (ISSN: 0929-8673linking), 2020 Feb 19; N/D: N/D-N/D.
Impact Factor: 4.184
Dettagli Esporta in BibTeX Esporta in EndNote
Alterio V, Kellner M, Esposito D, Liesche-starnecker F, Bua S, Supuran CT, Monti SM, Zeidler R, De Simone G
* Biochemical and structural insights into Carbonic Anhydrase XII/Fab6A10 complex (148 visite)
J Mol Biol (ISSN: 0022-2836linking, 1089-8638), 2019 Dec 6; 431(24): 4910-4921.
Impact Factor: 5.067
Dettagli Esporta in BibTeX Esporta in EndNote
Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (293 visite)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
Dettagli Esporta in BibTeX Esporta in EndNote
Calvanese L, Foca A, Sandomenico A, Foca G, Caporale A, Doti N, Iaccarino E, Leonardi A, D'Auria G, Ruvo M, Falcigno L
* Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy (471 visite)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 0968-0896linking), 2017 Dec 15; 25(24): 6589-6596.
Impact Factor: 2.881
Dettagli Esporta in BibTeX Esporta in EndNote
Berisio R, Squeglia F, Ruggiero A
* Editorial: Molecular Scenarios Behind Infectious Diseases (274 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2017 Nov 24; 24(36): 3939-3941.
Impact Factor: 3.469
Dettagli Esporta in BibTeX Esporta in EndNote
Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (962 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 2.774
Dettagli Esporta in BibTeX Esporta in EndNote
Di Matteo A, Franceschini M, Paiardini A, Grottesi A, Chiarella S, Rocchio S, Di Natale C, Marasco D, Vitagliano L, Travaglini-allocatelli C, Federici L
* Structural investigation of Nucleophosmin interaction with the tumor suppressor Fbw7γ (210 visite)
Oncogenesis (ISSN: 2157-9024), 2017; 6(9): N/D-N/D.
Impact Factor: 4.722
Dettagli Esporta in BibTeX Esporta in EndNote
Strizzi L, Sandomenico A, Margaryan NV, Foca A, Sanguigno L, Bodenstine TM, Chandler GS, Reed DW, Gilgur A, Seftor EA, Seftor RE, Khalkhali-ellis Z, Leonardi A, Ruvo M, Hendrix MJ
* Effects of a novel Nodal-targeting monoclonal antibody in melanoma (369 visite) (PDF 206 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic), 2015 Oct 27; 6(33): 34071-34086.
Impact Factor: 5.008
Dettagli Esporta in BibTeX Esporta in EndNote
Foca A, Sanguigno L, Foca G, Strizzi L, Iannitti R, Palumbo R, Hendrix MJ, Leonardi A, Ruvo M, Sandomenico A
* New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding (626 visite) (PDF 254 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2015 Sep 7; 16(9): 21342-21362.
Impact Factor: 3.257
Dettagli Esporta in BibTeX Esporta in EndNote
Calce E, Monfregola L, Saviano M, De Luca S
* HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor (532 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2015 May 20; 22(21): 2525-2538.
Impact Factor: 3.455
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (416 visite)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli Esporta in BibTeX Esporta in EndNote
Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (1315 visite)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
* Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors (320 visite)
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
Impact Factor: 1.461
Dettagli Esporta in BibTeX Esporta in EndNote
Monti SM, Supuran CT, De Simone G
* Carbonic anhydrase IX as a target for designing novel anticancer drugs (454 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 821-830.
Impact Factor: 4.07
Dettagli Esporta in BibTeX Esporta in EndNote
Vitagliano L, Fiume G, Scognamiglio PL, Doti N, Cannavo R, Puca A, Pedone C, Scala G, Quinto I, Marasco D
* Structural and functional insights into IkappaB-alpha/HIV-1 Tat interaction (531 visite)
Biochimie (ISSN: 0300-9084, 1638-6183, 1638-6183electronic), 2011 Sep; 93(9): 1592-1600.
Impact Factor: 3.022
Dettagli Esporta in BibTeX Esporta in EndNote
Perrone-filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A
* Molecular imaging of atherosclerosis in translational medicine (502 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 May; 38(5): 969-975.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A, Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (539 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli Esporta in BibTeX Esporta in EndNote
Napolitano M, Ottaiano A, Mauro F, Ieranò C, Satriano R, Pacelli R, Franco R, De Angelis V, Castello G, Scala S
* CD4(+)CD45RA(+)CXCR4(+) lymphocytes are inversely associated with progression in stages I-III melanoma patients (340 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 2010 Apr; 59(4): 511-517.
Impact Factor: 4.293
Dettagli Esporta in BibTeX Esporta in EndNote
Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (539 visite)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 2010 Feb 26; 285(9): 6563-6572.
Impact Factor: 5.328
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (374 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Greco A, Speranza A, Salvatore M
* Ultrasound molecular imaging by targeted microbubble contrast agents (366 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 97-110.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (566 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Milcinski M, Bischof Delaloye A
* Syllabus for postgraduate specialisation in Nuclear Medicine: 2006/07 update (316 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Mar; 34(3): 433-436.
Impact Factor: 4.101
Dettagli Esporta in BibTeX Esporta in EndNote
Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (339 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (489 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Palumbo R, Capasso D, Brescia F, Mita P, Sarti M, Bersani F, Scarfi MR
* Effects on apoptosis and reactive oxygen species formation by Jurkat cells exposed to 50 Hz electromagnetic fields (548 visite)
Bioelectromagnetics (ISSN: 0197-8462), 2006 Feb; 27(2): 159-162.
Impact Factor: 1.514
Dettagli Esporta in BibTeX Esporta in EndNote
D'Andrea LD, Del Gatto A, Pedone C, Benedetti E
* Peptide-based molecules in angiogenesis (648 visite)
Chem Biol Drug Des (ISSN: 1747-0277, 1747-0285, 1747-0277linking), 2006 Feb; 67(2): 115-126.
Impact Factor: 2.507
Dettagli Esporta in BibTeX Esporta in EndNote
Verdoliva A, Marasco D, De Capua A, Saporito A, Bellofiore P, Manfredi V, Fattorusso R, Pedone C, Ruvo M
* A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library (446 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2005 Jul; 6(7): 1242-1253.
Impact Factor: 3.94
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (434 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli Esporta in BibTeX Esporta in EndNote
Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
* Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα (337 visite)
Oncogene (ISSN: 0950-9232, 1476-5594), 2003; 22(21): 3330-3342.
Impact Factor: 6.495
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (434 visite)
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli Esporta in BibTeX Esporta in EndNote
Marino M, Rossi M, Ruvo M, Fassina G
* Novel molecular targets for systemic lupus erythematosus (340 visite)
Curr Drug Targets (ISSN: 1389-4501), 2002 Jun; 3(3): 223-228.
Impact Factor: 3.597
Dettagli Esporta in BibTeX Esporta in EndNote
Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, Russo GL
Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line (365 visite)
Febs Lett (ISSN: 0014-5793, 0014-5793print, 1873-3468electronic), 1999 Dec 3; 462(3): 322-328.
Impact Factor: 3.72
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (246 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Impact Factor: 1.623
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (307 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Cheung NKV, Bridger GJ, Shen SQ, Finn RD, Abrams RJ, Larson SM
Technetium-99m-Monoclonal Antibody Radio-Labeled Via Hydrazino Nicotinamide Derivative For Imaging Ganglioside Gd2-Positive Tumors (239 visite)
Nucl Med Biol, 1999; 26: 681-686.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (254 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M
Fractional retention of technetium-99m-sestamibi as an index of P- glycoprotein expression in untreated breast cancer patients (566 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 Sep; 38(9): 1348-1351.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (246 visite)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli Esporta in BibTeX Esporta in EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (420 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Latella G, Fonti R, Caprilli R, Marcheggiano A, Magliocca F, Das KM, Gambús G, Sambuy Y
Characterization of the mucins produced by normal human colonocytes in primary culture (254 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 1996; 11(2): 76-83.
Impact Factor: 0.732
Dettagli Esporta in BibTeX Esporta in EndNote
Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies (425 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1994 Oct 15; 54(20): 5445-5454.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB (290 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 1993 Sep; 37(3): 150-156.
Impact Factor: 1.269
Dettagli Esporta in BibTeX Esporta in EndNote
Sofia M, Del Vecchio S, Petrillo A, Mormile M, Salvatore M, Carratù L
Endobronchial deposition of radioactive monoclonal antibody in patients with inoperable non-small-cell carcinoma of the lung [4] (259 visite)
Chest (ISSN: 0012-3692), 1992 Nov; 102(5): 1632-1634.
Impact Factor: 2.341
Dettagli Esporta in BibTeX Esporta in EndNote
D'Aiuto G, Del Vecchio S, Mansi L, D'Aprile M, Botti G, Salvatore M
Malignant melanoma of the nipple: A case studied with radiolabeled monoclonal antibody (589 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 1991 Oct 31; 77(5): 449-451.
Impact Factor: 0.408
Dettagli Esporta in BibTeX Esporta in EndNote
Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (431 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (373 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (262 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (261 visite)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC
NONUNIFORM DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY IN TUMOR (236 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1990 Jul; 31(7): 1252-1252.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Trischitta V, Wong KY, Brunetti A, Scalisi R, Vigneri R, Goldfine ID
Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase (304 visite)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 1989 Mar 25; 264(9): 5041-5046.
Impact Factor: 6.963
Dettagli Esporta in BibTeX Esporta in EndNote
d'Onofrio G, Menichella G, Zini G, Rumi C, Pierelli L, Quarantelli M, Puggioni PL, Mango G
Lymphocyte subset counting by immunoperoxidase using an automated routine hematologic analyzer (358 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1989 Mar; 74(2): 137-142.
Impact Factor: 2.56
Dettagli Esporta in BibTeX Esporta in EndNote
Reynolds JC, Del Vecchio S, Sakahara H, Lora ME, Carrasquillo JA, Neumann RD, Larson SM
ANTI-MURINE ANTIBODY RESPONSE TO MOUSE MONOCLONAL ANTIBODIES CLINICAL FINDINGS AND IMPLICATIONS (548 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 121-125.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore M, Lastoria S, Del Vecchio S, Mansi L
Detection of colon cancer with radiolabelled monoclonal antibodies (280 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1989; 16(2): 103-104.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC
DETERMINATION OF ANTIGEN CONCENTRATION AND DISTRIBUTION IN HUMAN TUMORS THE QUANTITATIVE AUTORADIOGRAPHIC APPROACH (278 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 143-145.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (304 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
DEL VECCHIO S, MANSI L, GAGLIARDI N, PETRILLO A, SOFIA M, CARRATU L, SALVATORE M
INTRABRONCHIAL ADMINISTRATION OF IODINE-131 B72. 3 MONOCLONAL ANTIBODY IN PATIENTS WITH LUNG CANCER (288 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1988; 14(5-6): N/D-N/D.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (498 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
60 Records (57 escludendo Abstract e Conferenze).
Impact factor totale: 225.988 (218.344 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 243.443 (232.408 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Sivaccumar JP, Leonardi A, Iaccarino E, Corvino G, Sanguigno L, Chambery A, Russo R, Valletta M, Latino D, Capasso D, Doti N, Ruvo M, Sandomenico A
* Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry (3 visite)
Int J Mol Sci (ISSN: 1422-0067linking), 2021 Mar 20; 22(6): N/D-N/D.
Impact Factor: 4.556
Dettagli Esporta in BibTeX Esporta in EndNote
Camorani S, Passariello M, Agnello L, Esposito S, Collina F, Cantile M, Di Bonito M, Ulasov IV, Fedele M, Zannetti A, De Lorenzo C, Cerchia L
* Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer (78 visite) (PDF 41 visite)
J Exp Clin Cancer Res (ISSN: 0392-9078linking), 2020 Sep 7; 39(1): 180-180.
Impact Factor: 7.068
Dettagli Esporta in BibTeX Esporta in EndNote
Sivaccumar J, Sandomenico A, Vitagliano L, Ruvo M
* Monoclonal antibodies: A prospective and retrospective view (47 visite)
Curr Med Chem (ISSN: 0929-8673linking), 2020 Feb 19; N/D: N/D-N/D.
Impact Factor: 4.184
Dettagli Esporta in BibTeX Esporta in EndNote
Alterio V, Kellner M, Esposito D, Liesche-starnecker F, Bua S, Supuran CT, Monti SM, Zeidler R, De Simone G
* Biochemical and structural insights into Carbonic Anhydrase XII/Fab6A10 complex (148 visite)
J Mol Biol (ISSN: 0022-2836linking, 1089-8638), 2019 Dec 6; 431(24): 4910-4921.
Impact Factor: 5.067
Dettagli Esporta in BibTeX Esporta in EndNote
Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (293 visite)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
Dettagli Esporta in BibTeX Esporta in EndNote
Calvanese L, Foca A, Sandomenico A, Foca G, Caporale A, Doti N, Iaccarino E, Leonardi A, D'Auria G, Ruvo M, Falcigno L
* Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy (471 visite)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 0968-0896linking), 2017 Dec 15; 25(24): 6589-6596.
Impact Factor: 2.881
Dettagli Esporta in BibTeX Esporta in EndNote
Berisio R, Squeglia F, Ruggiero A
* Editorial: Molecular Scenarios Behind Infectious Diseases (274 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2017 Nov 24; 24(36): 3939-3941.
Impact Factor: 3.469
Dettagli Esporta in BibTeX Esporta in EndNote
Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (962 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 2.774
Dettagli Esporta in BibTeX Esporta in EndNote
Di Matteo A, Franceschini M, Paiardini A, Grottesi A, Chiarella S, Rocchio S, Di Natale C, Marasco D, Vitagliano L, Travaglini-allocatelli C, Federici L
* Structural investigation of Nucleophosmin interaction with the tumor suppressor Fbw7γ (210 visite)
Oncogenesis (ISSN: 2157-9024), 2017; 6(9): N/D-N/D.
Impact Factor: 4.722
Dettagli Esporta in BibTeX Esporta in EndNote
Strizzi L, Sandomenico A, Margaryan NV, Foca A, Sanguigno L, Bodenstine TM, Chandler GS, Reed DW, Gilgur A, Seftor EA, Seftor RE, Khalkhali-ellis Z, Leonardi A, Ruvo M, Hendrix MJ
* Effects of a novel Nodal-targeting monoclonal antibody in melanoma (369 visite) (PDF 206 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic), 2015 Oct 27; 6(33): 34071-34086.
Impact Factor: 5.008
Dettagli Esporta in BibTeX Esporta in EndNote
Foca A, Sanguigno L, Foca G, Strizzi L, Iannitti R, Palumbo R, Hendrix MJ, Leonardi A, Ruvo M, Sandomenico A
* New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding (626 visite) (PDF 254 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2015 Sep 7; 16(9): 21342-21362.
Impact Factor: 3.257
Dettagli Esporta in BibTeX Esporta in EndNote
Calce E, Monfregola L, Saviano M, De Luca S
* HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor (532 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2015 May 20; 22(21): 2525-2538.
Impact Factor: 3.455
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (416 visite)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli Esporta in BibTeX Esporta in EndNote
Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (1315 visite)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
* Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors (320 visite)
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
Impact Factor: 1.461
Dettagli Esporta in BibTeX Esporta in EndNote
Monti SM, Supuran CT, De Simone G
* Carbonic anhydrase IX as a target for designing novel anticancer drugs (454 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 821-830.
Impact Factor: 4.07
Dettagli Esporta in BibTeX Esporta in EndNote
Vitagliano L, Fiume G, Scognamiglio PL, Doti N, Cannavo R, Puca A, Pedone C, Scala G, Quinto I, Marasco D
* Structural and functional insights into IkappaB-alpha/HIV-1 Tat interaction (531 visite)
Biochimie (ISSN: 0300-9084, 1638-6183, 1638-6183electronic), 2011 Sep; 93(9): 1592-1600.
Impact Factor: 3.022
Dettagli Esporta in BibTeX Esporta in EndNote
Perrone-filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A
* Molecular imaging of atherosclerosis in translational medicine (502 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 May; 38(5): 969-975.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A, Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (539 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli Esporta in BibTeX Esporta in EndNote
Napolitano M, Ottaiano A, Mauro F, Ieranò C, Satriano R, Pacelli R, Franco R, De Angelis V, Castello G, Scala S
* CD4(+)CD45RA(+)CXCR4(+) lymphocytes are inversely associated with progression in stages I-III melanoma patients (340 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 2010 Apr; 59(4): 511-517.
Impact Factor: 4.293
Dettagli Esporta in BibTeX Esporta in EndNote
Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (539 visite)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 2010 Feb 26; 285(9): 6563-6572.
Impact Factor: 5.328
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (374 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Greco A, Speranza A, Salvatore M
* Ultrasound molecular imaging by targeted microbubble contrast agents (366 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 97-110.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (566 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Milcinski M, Bischof Delaloye A
* Syllabus for postgraduate specialisation in Nuclear Medicine: 2006/07 update (316 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Mar; 34(3): 433-436.
Impact Factor: 4.101
Dettagli Esporta in BibTeX Esporta in EndNote
Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (339 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (489 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Palumbo R, Capasso D, Brescia F, Mita P, Sarti M, Bersani F, Scarfi MR
* Effects on apoptosis and reactive oxygen species formation by Jurkat cells exposed to 50 Hz electromagnetic fields (548 visite)
Bioelectromagnetics (ISSN: 0197-8462), 2006 Feb; 27(2): 159-162.
Impact Factor: 1.514
Dettagli Esporta in BibTeX Esporta in EndNote
D'Andrea LD, Del Gatto A, Pedone C, Benedetti E
* Peptide-based molecules in angiogenesis (648 visite)
Chem Biol Drug Des (ISSN: 1747-0277, 1747-0285, 1747-0277linking), 2006 Feb; 67(2): 115-126.
Impact Factor: 2.507
Dettagli Esporta in BibTeX Esporta in EndNote
Verdoliva A, Marasco D, De Capua A, Saporito A, Bellofiore P, Manfredi V, Fattorusso R, Pedone C, Ruvo M
* A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library (446 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2005 Jul; 6(7): 1242-1253.
Impact Factor: 3.94
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (434 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli Esporta in BibTeX Esporta in EndNote
Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
* Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα (337 visite)
Oncogene (ISSN: 0950-9232, 1476-5594), 2003; 22(21): 3330-3342.
Impact Factor: 6.495
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (434 visite)
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli Esporta in BibTeX Esporta in EndNote
Marino M, Rossi M, Ruvo M, Fassina G
* Novel molecular targets for systemic lupus erythematosus (340 visite)
Curr Drug Targets (ISSN: 1389-4501), 2002 Jun; 3(3): 223-228.
Impact Factor: 3.597
Dettagli Esporta in BibTeX Esporta in EndNote
Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, Russo GL
Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line (365 visite)
Febs Lett (ISSN: 0014-5793, 0014-5793print, 1873-3468electronic), 1999 Dec 3; 462(3): 322-328.
Impact Factor: 3.72
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (246 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Impact Factor: 1.623
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (307 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
Dettagli Esporta in BibTeX Esporta in EndNote
Fonti R, Cheung NKV, Bridger GJ, Shen SQ, Finn RD, Abrams RJ, Larson SM
Technetium-99m-Monoclonal Antibody Radio-Labeled Via Hydrazino Nicotinamide Derivative For Imaging Ganglioside Gd2-Positive Tumors (239 visite)
Nucl Med Biol, 1999; 26: 681-686.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (254 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M
Fractional retention of technetium-99m-sestamibi as an index of P- glycoprotein expression in untreated breast cancer patients (566 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 Sep; 38(9): 1348-1351.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (246 visite)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli Esporta in BibTeX Esporta in EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (420 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Latella G, Fonti R, Caprilli R, Marcheggiano A, Magliocca F, Das KM, Gambús G, Sambuy Y
Characterization of the mucins produced by normal human colonocytes in primary culture (254 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 1996; 11(2): 76-83.
Impact Factor: 0.732
Dettagli Esporta in BibTeX Esporta in EndNote
Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies (425 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1994 Oct 15; 54(20): 5445-5454.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB (290 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 1993 Sep; 37(3): 150-156.
Impact Factor: 1.269
Dettagli Esporta in BibTeX Esporta in EndNote
Sofia M, Del Vecchio S, Petrillo A, Mormile M, Salvatore M, Carratù L
Endobronchial deposition of radioactive monoclonal antibody in patients with inoperable non-small-cell carcinoma of the lung [4] (259 visite)
Chest (ISSN: 0012-3692), 1992 Nov; 102(5): 1632-1634.
Impact Factor: 2.341
Dettagli Esporta in BibTeX Esporta in EndNote
D'Aiuto G, Del Vecchio S, Mansi L, D'Aprile M, Botti G, Salvatore M
Malignant melanoma of the nipple: A case studied with radiolabeled monoclonal antibody (589 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 1991 Oct 31; 77(5): 449-451.
Impact Factor: 0.408
Dettagli Esporta in BibTeX Esporta in EndNote
Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (431 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (373 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (262 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (261 visite)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC
NONUNIFORM DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY IN TUMOR (236 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1990 Jul; 31(7): 1252-1252.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Trischitta V, Wong KY, Brunetti A, Scalisi R, Vigneri R, Goldfine ID
Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase (304 visite)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 1989 Mar 25; 264(9): 5041-5046.
Impact Factor: 6.963
Dettagli Esporta in BibTeX Esporta in EndNote
d'Onofrio G, Menichella G, Zini G, Rumi C, Pierelli L, Quarantelli M, Puggioni PL, Mango G
Lymphocyte subset counting by immunoperoxidase using an automated routine hematologic analyzer (358 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1989 Mar; 74(2): 137-142.
Impact Factor: 2.56
Dettagli Esporta in BibTeX Esporta in EndNote
Reynolds JC, Del Vecchio S, Sakahara H, Lora ME, Carrasquillo JA, Neumann RD, Larson SM
ANTI-MURINE ANTIBODY RESPONSE TO MOUSE MONOCLONAL ANTIBODIES CLINICAL FINDINGS AND IMPLICATIONS (548 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 121-125.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore M, Lastoria S, Del Vecchio S, Mansi L
Detection of colon cancer with radiolabelled monoclonal antibodies (280 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1989; 16(2): 103-104.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC
DETERMINATION OF ANTIGEN CONCENTRATION AND DISTRIBUTION IN HUMAN TUMORS THE QUANTITATIVE AUTORADIOGRAPHIC APPROACH (278 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 143-145.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (304 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
DEL VECCHIO S, MANSI L, GAGLIARDI N, PETRILLO A, SOFIA M, CARRATU L, SALVATORE M
INTRABRONCHIAL ADMINISTRATION OF IODINE-131 B72. 3 MONOCLONAL ANTIBODY IN PATIENTS WITH LUNG CANCER (288 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1988; 14(5-6): N/D-N/D.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (498 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
60 Records (57 escludendo Abstract e Conferenze).
Impact factor totale: 225.988 (218.344 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 243.443 (232.408 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:56
357 views visite. Last view on Ultima visita in data Monday 23 August 2021, 7:48:21
ibb.cnr.it